Article · 29 Jun 2026
Conference abstract
Pollen food syndrome: Clinical utility of molecular allergy (component) testing in the management
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Pollen Food Syndrome, in particular Oral Allergy Syndrome (OAS) has been increasing in adults. As it is often difficult to assess the risk for anaphylaxis, a number of these patients are prescribed adrenaline autoinjectors for oral allergy syndrome to peanut and tree nuts with the associated anxiety of carrying an adrenaline autoinjector. Molecular component testing has revolutionized the management of these patients. Patients with symptoms of OAS who have been prescribed an adrenaline autoinjector because of throat tightness and features of anxiety, who have PR-10 / Bet v 1 proteins only and have a safe single blind food challenge and have their adrenaline autoinjectors removed with reassurance that they are not at risk of anaphylaxis, with significant improvement in their quality of life. The talk will present patients from my practice that have had their adrenaline removed following molecular allergy testing and oral challenges, and also patients with less striking history of nut reaction, but molecular testing has identified storage protein sensitization and the risk for anaphylaxis confirmed from this and adrenaline prescribed based on these tests.
Keywords
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Allergy & Therapy.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Allergy & Therapy
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Vincent St Aubyn Crump”
